(PR Web Via Acquire Media NewsEdge) Albany, NY (PRWEB) February 25, 2014
MRRBIZ Annauncess that Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players
Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players’, which provides in-depth analysis of the key therapeutic indications of oncology, breast cancer, colorectal cancer, prostate cancer, lung cancer and Non-Hodgkin’s Lymphoma (NHL), with forecasts until 2018. It also looks at treatment usage patterns and includes insights into the oncology R&D pipeline.
The Indian oncology therapeutics market for breast cancer, lung cancer, colorectal cancer, prostate cancer and NHL was estimated to be worth $153.3m in 2011, having grown at a Compound Annual Growth Rate (CAGR) of 12.7% from 2004. It is expected to reach $238.8m in 2018 at a CAGR of 6.5% from 2011. The slower growth in the forecast period is mainly due to the reduction in the price of leading marketed products for breast cancer, colorectal cancer, lung cancer and NHL after all 348 drugs on the National List of Essential Medicines (NLEM) are brought under price control regulations.
The limitations of the current market are unclear patent laws, restrictive pricing and reimbursement policies, ailing infrastructure, and insufficient government aid. Low patient affordability is also a major restraint, and one that reimbursement and insurance policies must address if the market is to develop in the future.
The report analyzes treatment usage patterns, market characterization, pipeline analysis, competitive landscape and key M&A trends in the breast cancer, colorectal cancer, prostate cancer, lung cancer and NHL markets.
The report includes:
Data and analysis for the oncology therapeutics market in India
Annualized market data for the oncology therapeutics market in India from 2004 to 2011, with forecasts to 2018
Key drivers and restraints that have had a significant impact on the market
The competitive landscape of the oncology therapeutics market in India
Key M&A activities and licensing agreements that have taken place in the Indian oncology therapeutics market
To download sample report visit at http://www.marketresearchreports.biz/sample/sample/165776.
Reasons to Buy
The report will enhance your decision-making capability by allowing you to:
Align your product portfolio to the markets with high growth potential
Develop market-entry and market-expansion strategies by identifying the potential regions and therapeutic segments poised for strong growth
Devise a more effectively tailored country strategy through the understanding of key drivers and barriers in the oncology market
Develop key strategic initiatives by understanding the key focus areas and leading companies
Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships
Visit Analysis Report: http://www.marketresearchreports.biz/analysis/165776.
Table of Contents
1 Table of Contents
2 Oncology Therapeutics Market in India – Executive Summary
3 Oncology Therapeutics Market in India – Introduction
4 Oncology Therapeutics Market in India – Market Overview
5 Oncology Therapeutics Market in India – Therapeutic Landscape
6 Oncology Therapeutics Market in India – Pipeline Analysis
7 Oncology Therapeutics Market in India – Competitive Landscape
8 Oncology Therapeutics Market in India – Strategic Consolidations
9 Oncology Therapeutics Market in India – Appendix
All Natural Food and Drinks Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis/188680
The All Natural Food and Drinks refer to foods and drinks which are minimally processed. The All-natural Food and Drinks market is an alternative to the organic foods or the products labelled as “free from”. The demand from the developed markets such as the U.S., the U.K., and Germany is expected to increase in the coming years. The consumer preferences for foods with non-genetically modified ingredients are compelling the industry to manufacture products free from such ingredients. The heavy lobbying by the people in the U.S. has compelled Food and Drugs Association to redefine labelling of the products with the genetically modified ingredients. The European countries have already banned such products as they are harmful for humans, animals and also environment. Ban and reduced production of such products would support the growth of All Natural Food and Drinks market.
The product segments for All Natural Food and Drinks market include All-Natural Food and Drink and All-natural Food and Drink ingredients. The latter can be further categorized under Natural Flavours, Natural Colours, Natural Sweeteners, Natural Preservatives, Other ingredients and Non-ingredients. Some of the major global companies operating in the market are Nestle, Archer Daniels, Bunge, General Mills, Tyson Foods and Con-Agra Foods.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
Rest of the World
This report provides comprehensive analysis of:
Market growth drivers
Factors limiting market growth
Current market trends
Market projections for upcoming years
Request Sample: http://www.marketresearchreports.biz/sample/toc/188680
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Bone and Joints Ingredients Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 : http://www.marketresearchreports.biz/analysis/188681
Bone and joints ingredients are those elements which are taken as supplement in order to maintain healthy bones and joints. These value added ingredients help in increasing the strength and flexibility of the bones and joints in the body. There are various bone and joint ingredients including calcium, soy isoflavone and collagen. For instance, calcium is the most popular bone ingredient. It is an established ingredient with a mature market. Soy isoflavone is another key bone health ingredient maintaining bone mineral density (BMD) and preventing bone loss. The most important ingredients of joint ingredient market are glucosamine and chondroitin. Collagen, eggshell membrane and olive polyphenols are other ingredients which stimulate joint function and mobility.
The global market for bone and joints ingredients is growing rapidly due to rising use of these ingredients in different parts of the world. Increase in ageing population is considered as one the major driving factors for the market. Due to weakening of bone and joints, diminished functions and movements, ageing makes body more prone to bone fractures, arthritis, back and neck pain, osteoporosis and injuries. The number of aged people over 60 years or over are expected to double in the next 50 years, thereby increasing demand for these ingredients in the market. Despite the benefits of bone and joint health ingredients, the growing concerns for fatal diseases, such as cancer and heart, are some of the major restraints for the market. On the other hand, introduction of various pills which reduces the inflammation of joint and may cure the symptoms of arthritis acts as a challenge for the market. In addition, many stringent laws, regulations and procedural formalities that are imposed on the vendors are also posing challenge for the market.
On the basis of volume the market is segmented into Calcium, Glucosamine, Chondroitin and others. On the basis of market share, the market is segmented into dietary supplements and functional food beverages. Some of the major players operating in the market are Archer Daniels Midland (ADM), BASF SE, DuPont and Royal DSM NV.